double-blind, randomized, placebo-controlled study investigating the
safety and tolerability of deferiprone in patients with Friedreich's
ataxia. "
This is a world wide study being run in Europe, Australia and Canada.
Criteria seems to be "7 to 35 years of age, has a confirmed genetic
diagnosis of FRDA with number of GAA repeats greater or equal to 400 on
both copies of DNA, has a score between 20 and 85 on a neurological exam
known as Friedreich's Ataxia Rating Scale (FARS), has a negative urine
pregnancy test (if applicable) before the research study starts and is
currently not participating in another research study. "
further information, on
Name: Ms Geneieve Tai
Role: Research Coordinator
Telephone: (03) 8341 6374
cheers all
--
Laurel Hosking
Help FA in SA
mob: 04204 98963
ph: 08 85221167
fax: 08 85221313
laurel@linvid.com
No comments:
Post a Comment